Kyowa Kirin’s Poteligeo to Receive Additional Indication for Incipient Untreated ATL, Will Be Added to mLSG15 Therapy

The Ministry of Health, Labor and Welfare (MHLW) reported to the Pharmaceutical Affairs and Food Sanitation Council’s Second Committee on Drugs on November 28 that Kyowa Hakko Kirin’s adult T-cell leukemia (ATL) treatment Poteligeo Injection 20 mg (mogamulizumab (recombinant)) will...read more